|
67
|
208
|
4xirA |
Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors |
|
69
|
209
|
4xiqA |
Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors |
|
120
|
361
|
4v25A |
Ver-246608, a novel pan-isoform atp competitive inhibitor of pyruvate dehydrogenase kinase, disrupts warburg metabolism and induces context- dependent cytostasis in cancer cells |
|
132
|
389
|
4wudA |
N-terminal 43 kda fragment of the e. coli dna gyrase b subunit grown from no salt condition |
|
50
|
213
|
4x9lA |
N-terminal domain of heat shock protein 90 from oryza sativa |
|
125
|
361
|
4v26A |
Ver-246608, a novel pan-isoform atp competitive inhibitor of pyruvate dehydrogenase kinase, disrupts warburg metabolism and induces context- dependent cytostasis in cancer cells |
|
132
|
389
|
4wucA |
N-terminal 43 kda fragment of the e. coli dna gyrase b subunit grown from 100 mm nacl condition |
|
57
|
207
|
4urmA |
Crystal structure of staph gyraseb 24kda in complex with kibdelomycin |
|
131
|
389
|
4wubA |
N-terminal 43 kda fragment of the e. coli dna gyrase b subunit grown from 100 mm kcl condition |
|
74
|
214
|
4xclA |
N-terminal domain of hsp90 from dictyostelium discoideum in complex with ags |
|
66
|
207
|
4w7tA |
Crystal structure of hsp90-alpha n-domain bound to the inhibitor nvp-hsp990 |
|
53
|
206
|
4uroA |
Crystal structure of staph gyraseb 24kda in complex with novobiocin |
|
68
|
207
|
4u93A |
Crystal structure of hsp90-alpha n-domain bound to the inhibitor nvp-hsp990 |
|
79
|
239
|
4u7oA |
Active histidine kinase bound with atp |
|
69
|
225
|
4u7nA |
Inactive structure of histidine kinase |
|
113
|
394
|
4r1fA |
Re-refined human dna topoisomerase iia (atpase and transducer domains) in complex with adp and so4 |
|
66
|
209
|
4r3mA |
Crystal structure of human hsp90 with jr9 |
|
123
|
385
|
4pu9A |
E. coli gyrb 43-kda n-terminal fragment in complex with adp-bef3 |
|
124
|
382
|
4prvA |
E. coli gyrb 43-kda n-terminal fragment in complex with adp |
|
57
|
184
|
4p8oA |
S. aureus gyrase bound to an aminobenzimidazole urea inhibitor |
|
108
|
374
|
4prxA |
E. coli gyrb 43-kda n-terminal fragment in complex with adp+pi |
|
42
|
176
|
4pl9A |
Structure of the catalytic domain of etr1 from arabidopsis thaliana |
|
77
|
233
|
4q20A |
Crystal structure of a c-terminal part of tyrosine kinase (divl) from caulobacter crescentus cb15 at 2.50 a resolution (psi community target, shapiro) |
|
67
|
209
|
4o07A |
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease |
|
68
|
209
|
4nh8A |
Correlation between chemotype-dependent binding conformations of hsp90 alpha/beta and isoform selectivity |
|
66
|
209
|
4o05A |
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease |
|
55
|
265
|
4nh9A |
Correlation between chemotype-dependent binding conformations of hsp90 alpha/beta and isoform selectivity |
|
66
|
208
|
4o04A |
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease |
|
70
|
208
|
4nh7A |
Correlation between chemotype-dependent binding conformations of hsp90 alpha/beta and isoform selectivity |
|
67
|
209
|
4o0bA |
Identification of novel hsp90/isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington's disease |
|
69
|
209
|
4o09A |
Identification of novel hsp90 / isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington s disease |
|
135
|
383
|
4mpnA |
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps10 |
|
68
|
207
|
4lwgA |
Crystal structure of the human hsp90-alpha n-domain bound to the hsp90 inhibitor fj4 |
|
60
|
210
|
4lpbA |
Crystal structure of a topoisomerase atpase inhibitor |
|
135
|
383
|
4mpeA |
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps8 |
|
137
|
381
|
4mp2A |
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor pa1 |
|
68
|
208
|
4lweA |
Crystal structure of the human hsp90-alpha n-domain bound to the hsp90 inhibitor fj2 |
|
60
|
210
|
4motA |
Structure of streptococcus pneumonia pare in complex with az13072886 |
|
68
|
207
|
4lwfA |
Crystal structure of the human hsp90-alpha n-domain bound to the hsp90 inhibitor fj3 |
|
137
|
383
|
4mp7A |
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor pa7 |
|
68
|
208
|
4lwhA |
Crystal structure of the human hsp90-alpha n-domain bound to the hsp90 inhibitor fj5 |
|
58
|
210
|
4lp0A |
Crystal structure of a topoisomerase atp inhibitor |
|
132
|
383
|
4mpcA |
Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps2 |
|
62
|
207
|
4lwiA |
Crystal structure of the human hsp90-alpha n-domain bound to the hsp90 inhibitor fj6 |
|
62
|
210
|
4k4oA |
The dna gyrase b atp binding domain of enterococcus faecalis in complex with a small molecule inhibitor |
|
68
|
207
|
4l94A |
Crystal structure of human hsp90 with s46 |
|
108
|
374
|
4kqvA |
Topoisomerase iv atp binding domain of francisella tularensis in complex with a small molecule inhibitor |
|
71
|
208
|
4l8zA |
Crystal structure of human hsp90 with rl1 |
|
69
|
208
|
4l90A |
Crystal structure of human hsp90 with rl3 |
|
70
|
207
|
4l91A |
Crystal structure of human hsp90 with x29 |
